Review, 2026
What should doctors know about PMS and PMDD in teenagers?
PMS and PMDD are common in teenagers and affect school, friendships, and mental health because the body is overly sensitive to normal hormone changes. SSRIs (antidepressants), birth control pills, exercise, therapy, and lifestyle changes can help, though most evidence comes from adult studies.
What they did
A structured review of research on how premenstrual disorders develop, present, and can be treated in adolescents, with emphasis on adolescent-specific evidence.
What they found
PMS and PMDD affect school functioning, relationships, and psychological well-being in adolescents. Symptoms overlap with normal puberty and psychiatric disorders, making diagnosis challenging. SSRIs and combined oral contraceptives help, along with psychological, lifestyle, physical activity, and physiotherapy approaches.
What it means for you
Doctors should diagnose PMS and PMDD in teenagers by tracking symptoms over time and tailor treatment to their age. Main limitation: most treatment evidence comes from adult studies, not from adolescent-specific research.
About the study
- Original title
- Premenstrual Disorders in Adolescents: An Interdisciplinary Perspective
- Authors
- Dobrzeniecki K, Kacprzak M, Stachecka D et al.
- Journal
- Journal of clinical medicine
- Year
- 2026
- Study design
- Review
- What was tested
- SSRIs, combined oral contraceptives, psychological interventions, lifestyle changes, physical activity, physiotherapy
- Open access
- Yes
- Read the paper
- doi.org/10.3390/jcm15187046
Original abstract
Background: Premenstrual disorders (PMDs), including premenstrual syndrome and premenstrual dysphoric disorder, are common conditions that may substantially affect adolescents' physical and psychological well-being. However, their presentation and management during adolescence are complicated by reproductive-axis maturation, overlap with other medical conditions, and limited adolescent-specific evidence. This review aimed to provide an interdisciplinary perspective on PMDs in adolescents, integrating biological, psychological, developmental, clinical, and sociocultural aspects. Methods: A structured narrative review was conducted. Publications addressing the neuroendocrine and developmental mechanisms, clinical manifestations, psychosocial consequences, diagnosis, and treatment of PMDs were considered, with adolescent-specific evidence prioritized where available. Results: Current evidence suggests that PMDs are associated with altered sensitivity to physiological ovarian steroid fluctuations and their neuroactive effects rather than abnormal circulating hormone concentrations alone. In adolescents, PMDs may present with diverse somatic, affective, cognitive, and behavioral symptoms and are associated with impaired quality of life, school functioning, interpersonal relationships, and psychological well-being. Diagnostic assessment remains challenging because symptoms may overlap with normal pubertal changes and psychiatric disorders. Prospective monitoring of symptom cyclicity and functional impairment is therefore essential. Pharmacological treatments, particularly selective serotonin reuptake inhibitors and selected combined oral contraceptives, represent important therapeutic options, while psychological, lifestyle, physical activity, and physiotherapeutic interventions may provide additional benefits. However, most treatment evidence is derived from adult populations. Conclusions: PMDs in adolescents should be conceptualized as multidimensional conditions requiring an interdisciplinary approach integrating gynecological, psychiatric, psychological, endocrinological, primary care, and lifestyle perspectives. Greater recognition and developmentally appropriate assessment may facilitate earlier diagnosis and individualized management. Further prospective, adolescent-specific research is needed to clarify the biological and psychosocial determinants of PMDs and establish evidence-based strategies for their multidisciplinary management.
Reproduced under CC-BY.
Topics
Related studies
Study, 2022
What are the symptoms, causes, and treatments of PMS and PMDD?
Study, 2008
How common is PMDD and how does it affect women's lives?
Review, 2024
What are the most effective treatments for PMDD?
Randomised trial, 2023
Does taking sertraline when PMDD symptoms start improve how well women function?
Review, 2017
What causes PMDD and what are the best treatments?
Review, 2015
What do we know about PMS and PMDD and how are they treated?